Important Update

Statement regarding Aethlon’s position with respect to the potential for use of the Hemopurifier as a countermeasure against the current coronavirus SARS-CoV-2 (COVID-19) outbreak

Recent News

June 21, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

June 10, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

View All News

Upcoming Events

Jun 24, 2021 • 4:30pm EDT

Fourth Quarter 2021 Investor Call

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up